레이저옵텍 인터내셔널 웹페이지로 이동합니다. 인터내셔널 웹페이지의 내용은 해당 언어지역에서의 제품 정보에 관한 것으로 국내 제품 과는 품 목이 다를 수 있으며, 국내 소비자의 보호를 위한 국내법 상의 광고 심의,규제를 받지 않습니다. 페이지 이동을 계속하겠습니까?


You will be moved to the Laseroptek products web page. The content in the International web page contains product information in that region. The items may be different from the Korean products, and are not regulated by the advertising reviews of Korean laws for the protection of Korean cousumers. Would you like to continue moving to the page?

X

News

News > PR

LASEROPTEK, Picosecond laser, “PicoLO” FDA Cleared Laseroptek 2019.01.16


LASEROPTEK, medical and industrial laser system manufacturer, received US FDA 510(k) clearance for PicoLO as tattoo removal in last January 3rd.

PicoLO, which is Nd: YAG-based picosecond laser system with advanced technology, has a special feature that can destroy pigmented particles on deep dermal layer more effectively by high energy and short pulse duration.

Furthermore, LIOB (Laser-induced Optical Breakdown), which can be implemented by only picosecond laser, helps improvement on skin color, pores and scar regeneration by forming tiny bubbles on deep dermal layer without leaving any scars on skin surface and leading to skin rejuvenation.

Especially, PicoLO can create LIOB effect by using LASEROPTEK’s patented DOE Fractional handpiece.

LASEROPTEK already has received US FDA 510(k) for Er:YAG laser, LOTUS III in last December before PicoLO.

Chang Jin Lee, CEO and President of LASEROPTEK, said that we finished US FDA 510(k) clearance for main products from PALLAS (world first solid-state UV laser used for treating vitiligo, psoriasis, atopic dermatitis, and alopecia areata), LOTUS III, and up to PicoLO, so we will accelerate to penetrate North America market this year.

 

http://www.medical-tribune.co.kr/news/articleView.html?idxno=83579